Natural history of invasive cutaneous melanoma in Styria, Austria 2001-2003;Klinisch-epidemiologische daten des invasiven kutanen melanoms in der Steiermark, Österreich 2001-2003

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 4, 2007, Pages 293-299

  Richtig, Erika ^a   Gerger, Armin ^b   Berghold, Andrea ^b   Schwantzer, Gerold ^b   Ott, Arthur ^b   Kerl, Helmut ^a   Smolle, Josef ^b  

^a Universitatsklinik fur Dermatologie und Venerologie   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Austria; Cutaneous melanoma; Incidence; Styria

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; AUSTRIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CARDIOVASCULAR SYSTEM; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HISTORY; HUMAN; LIFESPAN; LIMB; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELANOMA; MICROSATELLITE MARKER; PATHOLOGICAL ANATOMY; SENTINEL LYMPH NODE BIOPSY; SEX RATIO; TRUNK; TUMOR VOLUME; ULCER; VISIBILITY;

AUSTRIA; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS;

EID: 33947584852     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06246.x     Document Type: Article

References (21)

1. Armstrong B. Epidemiology of cutaneous melanoma and current trends. In: Thompson JF, Morton DL, Kroon BBR: Textbook of melanoma. London: Dunitz, 2004: 65-80.
2. De Vries E, Bray FI, Coebergh JW, Parkin DM for the European Network of Cancer Registries. Changing Epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-126.
3. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001; 14: 280-290.
4. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumor stages and localization (epidermiology of skin cancer). Brit J Dermatol 2003; 149: 1200-1206.
5. Volkenandt M, Schmidt M, Konz B, Gummer M, Hein R, Plewig G, Hölzel D. Klinisch-epidemiologische Daten von Patienten mit malignen Melanomen aus dem Bereich des Tumorzentrums München von 1977 bis 1997. Hautarzt 1999; 50: 470-478.
6. Schmidt M, Hölzel D. Klinisch-epidemiologische Daten zum malignen Melanom aus dem Bereich des Tumorzentrums München. In: Volkenandt M, Plewig G: Maligne Melanome. Empfehlungen zur Diagnostik, Therapie und Nachsorge. 5.Edition. München: Zuckschwerdt, 2000: 2-6.
7. http://www.verwaltung.steiermark.at/cms/dokumente/10004611_97710/ 693bd9a3/Wbinsgesamt.pdf
8. Garbe C, Cerroni L, Kerl H. Melanozytäre Nävi und malignes Melanom. In: Kerl H, Garbe C, Cerroni L, Wolff HH: Histopathologie der Haut. Berlin: Springer Verlag, 2003: 593-649.
9. Balch CM, Buzaid AC, Seng-Jaw S, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. Journal Clin Oncol 2001; 19: 3635-3648.
10. Jones WO, Harman CR, Ng AK, Shaw JH. Incidence of malignant melanoma in Auckland, New Zealand: Highest rates in the world. World J Surg 1999; 23: 732-735.
11. Kölmel KF, Lippold A, Kulle B, Veltmaat S, Stoltenberg M, Seebacher C. Zur Sterblichkeit am kutanen invasiven malignen Melanom. Hautarzt 2001; 52: 211-218.
12. Rieger E, Soyer HP, Kofler R, Hödl S, Smolle J, Richtig E, Kerl H. Klinischepidemiologische Daten des malignen Melanoms anhand von 1368 Patienten der Grazer Universitäts-Hautklinik (1970-1989). Wien Klien Wochenschr 1991; 103/20: 612-616.
13. Pehamberger H. "10 Jahre Sonne ohne Reue". In: Onkologisch. Wayand W, Pehamberger H: Wien: Österreichische Krebshilfe- Krebsgesellschaft, 1998: 31.
14. Hofmann-Wellenhof R, Soyer HP, Richtig E, Wolf IH, Smolle J, Scherer C, Kerl H. Should dermatologists go public? A skin cancer screening campaign at recreation centers. Arch Dermatol 2000; 136: 938-940.
15. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000; 89/6: 1269-1278.
16. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238(4): 538-549.
17. Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003; 10(5): 569-574.
18. Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Arch Dermatol 2005; 141(8): 1016-1022.
19. Dore JF, Boniol M. Environment influences on cutaneous melanoma. In: Thompson JF, Morton DL, Kroon BBR: Textbook of melanoma. London: Dunitz, 2004: 43-55.
20. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene 2003; 22: 3042-3052.
21. Kittler H, Binder M, Wolff K, Pehamberger H. A ten-year analysis of demographic trends for cutaneous melanoma: Analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999). Wien Klin Wochenschr 2001; 113/9: 321-327.